Yongin-si, South Korea

Si Nae Lee


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Si Nae Lee: Innovator in Anti-Inflammatory Peptides

Introduction

Si Nae Lee is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides with anti-inflammatory properties. His work has the potential to impact various health-related applications, including drug formulations and health food compositions.

Latest Patents

Si Nae Lee holds a patent for his invention titled "Peptides and use thereof." This patent focuses on a peptide that exhibits anti-inflammatory effects. The invention encompasses a polynucleotide encoding the peptide, a pharmaceutical composition for preventing or treating inflammatory diseases, and various applications including over-the-counter drug compositions and cosmetic formulations aimed at alleviating inflammation. The methods outlined in the patent also include approaches for treating inflammatory diseases and designing peptide mimetics.

Career Highlights

Throughout his career, Si Nae Lee has worked with notable organizations, including the Samsung Life Public Welfare Foundation and Il-yang Pharm. Co., Ltd. His experience in these companies has allowed him to collaborate with other professionals in the field and contribute to advancements in pharmaceutical science.

Collaborations

Si Nae Lee has collaborated with colleagues such as Dae Ho Cho and Min Kyung Jung. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the development of innovative solutions in the realm of anti-inflammatory treatments.

Conclusion

Si Nae Lee's work in the field of peptides and their applications in treating inflammation showcases his innovative spirit and dedication to improving health outcomes. His contributions are paving the way for new therapeutic options in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…